Clinical Trial Update: Dazucorilant in Patients With Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

Corcept Therapeutics is conducting a Phase 2 trial of dazucorilant in patients with amyotrophic lateral sclerosis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Dazucorilant

Snippet

Sponsor: Corcept Therapeutics | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: RECRUITING